Matinas BioPharma Holdings, Inc.

$0.5721
-0.0029 (-0.50%)

Market Capitalization:

$3.66M

Matinas BioPharma Holdings Price Chart

Matinas BioPharma Holdings Price Chart11:59 AM1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM0.57910.57670.57440.57200.56970.56730.56

Matinas BioPharma Holdings Volume Chart

Matinas BioPharma Holdings Volume Chart11:59 AM1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM1.36K1.17K973778584389195

Matinas BioPharma Holdings Market Segments

After Hours

*No Trades in Segment

Regular Trading Hours

+0.0021(+0.37%)
Open$0.5700
Close$0.5721
Low$0.5646
Low Change-0.0054 (-0.95%)
High$0.5791
High Change+0.0091 (+1.60%)
Range$0.0145
Volume4.735K
Dollar Volume$2.71K

Premarket

+0.0000(+0.00%)
Open$0.5958
Close$0.5958
Low$0.5958
Low Change0.0000 (0.00%)
High$0.5958
High Change+0.0000 (+0.00%)
Range$0.0000
Volume165
Dollar Volume$98.31

After Hours Yesterday

*No Trades in Segment

Regular Trading Hours Yesterday

+0.0050(+0.88%)
Open$0.5700
Close$0.5750
Low$0.5700
Low Change0.0000 (0.00%)
High$0.5900
High Change+0.0200 (+3.51%)
Range$0.0200
Volume17.177K
Dollar Volume$9.88K

Premarket Yesterday

+0.0057(+1.00%)
Open$0.5700
Close$0.5757
Low$0.5700
Low Change0.0000 (0.00%)
High$0.5757
High Change+0.0057 (+1.00%)
Range$0.0057
Volume886
Dollar Volume$510.07

Matinas BioPharma Holdings Moving Averages

5 Day Moving Average (SMA5)$0.6176
10 Day Moving Average (SMA10)$0.6430
20 Day Moving Average (SMA20)$0.6077
50 Day Moving Average (SMA50)$0.5872
100 Day Moving Average (SMA100)$0.6150
200 Day Moving Average (SMA200)$1.0131

Matinas BioPharma Holdings Statistics

Average Volume (30 Days)33.57K
P/E Ratio (Current)-.34
EPS (Current)-$1.75
Dividend Yield0.00%
Free Cash Flow
Cash Ratio1.13
Current Ratio1.30
Quick Ratio1.30
Debt to Equity0.00
Enterprise Value$1.39M
EV to EBITDA-0.20
EV to Sales
Price to Book1.25
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-1.91%
Return on Equity-3.72%

Matinas BioPharma Holdings Stock Splits

There has been 1 stock split for Matinas BioPharma Holdings (MTNB). The reverse stock split occured on September 3, 2024 and reduced the outstanding shares at a ratio of 50:1.

DateTypeRatio
Sep 3, 2024Reverse50:1

Matinas BioPharma Holdings Dividends

There have been no dividends for Matinas BioPharma Holdings (MTNB).